Search - tctmd.com

Displaying 61 - 80 of 82

Sort: Relevancy | Date

News Daily News

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

Yael L. Maxwell

October 30, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

L.A. McKeown

April 28, 2015

News Daily News

元分析解释了不同DAPT时间长短的影响

Caitlin E. Cox

April 03, 2015

News Daily News

Un Meta Análisis Arrojan Luz sobre el Impacto de la Duración del Tratamiento Antiplaquetario Doble

Caitlin E. Cox

April 03, 2015

News Daily News

Meta-analyses Shed Light on the Impact of DAPT Duration

Caitlin E. Cox

April 03, 2015

News Daily News

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

January 29, 2015

News Conference News AHA 2014

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

Yael L. Maxwell

November 15, 2014

News Conference News AHA 2014

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

November 15, 2014

Presentation TCT 2014

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

Presenter: Fausto Feres

September 16, 2014

Presentation TCT 2014

TCT 481: Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus-Eluting Stent Implantation in OPTIMIZE

Presenter: Dietmar Trenk, Harvey D. White, Dominick J. Angiolillo, Fausto Feres

September 14, 2014

News Daily News

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

July 02, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

News Daily News

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Yael L. Maxwell

February 17, 2014

Presentation TCT 2013

Shorter Is Better: New Insights From OPTIMIZE, PARIS, and Other Studies

Presenter: Roxana Mehran

October 31, 2013

Presentation TCT 2013

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Presenter: Peter Wenaweser

October 31, 2013

Presentation TCT 2013

Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI

Presenter: Fausto Feres

October 31, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

News Daily News

Danish Registry: Dabigatran Safe, Effective in Real-World Use

Caitlin E. Cox

April 05, 2013

Presentation TCT 2012

A Preview to OPTIMIZE

Presenter: Fausto Feres

October 22, 2012

Advertisement

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

元分析解释了不同DAPT时间长短的影响

Un Meta Análisis Arrojan Luz sobre el Impacto de la Duración del Tratamiento Antiplaquetario Doble

Meta-analyses Shed Light on the Impact of DAPT Duration

Meta-analysis Evaluates Evidence for Clinical Impact of PPIs in Patients on DAPT

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

TCT 481: Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus-Eluting Stent Implantation in OPTIMIZE

CORONOR Registry: No Advantage to Prolonged DAPT in Stable CAD

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

DAPT Interruption At Least 1 Month After ZES Implantation Appears Safe

Shorter Is Better: New Insights From OPTIMIZE, PARIS, and Other Studies

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Danish Registry: Dabigatran Safe, Effective in Real-World Use

A Preview to OPTIMIZE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content